DLAT and hepatocellular carcinoma: In addition, we also analyzed the expression levels of DLAT, IDH3B, and MAP3K4 in HCC (Figure 3D) and their prognostic value in different clinical subgroups: T3 and T4 stage, pathological stage III and IV, fibrosis Ishak score 3–6, and Child–Pugh grade B and C. The results indicated that the lower expression of the three genes might be correlated with better prognosis in advanced patients (Figure 3E–G, Figure S1).